Gene Query: NFATC1

Dataset Description Geneva Score
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 67.72
Controlling for gene expression changes in transcription factor protein networks. 55.5
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 48.38
Peptidomimetic blockade of MYB in acute myeloid leukemia 39.75
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 39.75
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 37.72
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 33.8
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 33.8
ChIP-seq and RNA-seq from human lymphoma cell lines 33.27
RNA-seq data from human lymphoma cell lines 33.27
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 30.37
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 30.03
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 29.61
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 27.05
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 27.05
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 25.7
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 25.69
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 24.43
Transcriptomic profiling of human peripheral blood-derived mast cells 24.43
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 23.13
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 23.13
Characterization of human ILC2 subsets 21.73
Transcriptomic and gene ontology profiling of the human corneal cell types 21.04
Noncoding regions are the main source of targetable tumor-specific antigens 19.82
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 18.62
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 18.07
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 17.74
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 16.69
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 16.25
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 16.1
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 16.1
Transcriptome analysis of SKI knock-out in HL60 cells 16.1
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 15.59
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 15.59
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 15.07
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 15.07
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 14.83
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 14.53
Landscape of H3K4me3 in human CD19 cells 14.21
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 14.21
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 14.15
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 13.82
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 13.7
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 13.68
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 13.68
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 12.69
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 12.48
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 12.48
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 12.0
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 11.86
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 11.6
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 11.34
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 11.34
BI Human Reference Epigenome Mapping Project 11.18
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 10.94
Seletive inhibition of CDK9 in DLBCL cell lines 10.82
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 10.48
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 10.4
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 10.4
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 10.12
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 9.92
A role for ZNF598 in post-transcriptional gene regulation 9.78
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 9.47
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 9.33
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 9.32
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 9.19
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 8.99
RNA-seq analysis of RALD iPSCs after in vitro differentiation 8.97
Gene expression in PANC1 cells treated with Rakicidin 8.96
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 8.93
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 8.6
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 8.36
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 8.23
The evolution of N6-methyladenosine in primates 8.14
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 7.98
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 7.94
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 7.84
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 7.8
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 7.75
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 7.75
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 7.75
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 7.69
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 7.66
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 7.66
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 7.63
Differetially expressed genes after hTR overexpression in U2OS cells 7.57
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 7.47
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 7.47
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 7.44
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 7.23
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 7.22
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 7.22
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 7.06
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 7.06
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 7.03
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 6.89
EP400 is required for Max and MCPyV mediated gene activation 6.79
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 6.76
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 6.64
The expression profiles of GBC liver metastasis 6.61
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 6.55
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 6.55
Mechanistic Model-Guided Study of Embryonic Morphogenesis 6.52
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 6.31
RNA-sequencing of human tendon after injury 6.28
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 6.09
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 6.07
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 6.04
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 6.04
Ectoderm specification of H1 human embryonic stem cells 5.97
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 5.93
Gene expression changes associated with resistance to tagraxofusp (SL-401) 5.91
Dynamic 3D chromosomal landscapes in acute leukemia 5.9
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 5.9
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 5.88
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 5.87
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 5.86
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 5.8
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 5.8
Intrahepatic MAIT cell gene expression revealed by RNA-seq 5.78
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 5.75
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 5.68
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 5.59
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 5.59
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 5.59
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 5.55
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 5.54
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 5.45
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 5.43
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 5.37
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 5.3
Comparing gene expression in iPSC derived RPE from control and AMD donors 5.22
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 5.2
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 5.13
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 5.11
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 5.11
Bone marrow derived human B cells [normal proB] 5.05
FOXP1 orchestration of ASD-relevant signaling pathways. 4.8
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 4.77
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 4.74
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 4.73
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 4.59
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 4.58
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 4.58
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 4.52
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 4.52
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 4.5
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 4.5
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 4.5
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 4.47
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 4.47
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 4.4
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 4.4
Polarized B -cell functions 4.38
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 4.36
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 4.34
Primary Human B-cell Temporal Response to CD40L Stimulation 4.31
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 4.31
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 4.3
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 4.3
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 4.28
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 4.26
RNA-seq in transgenic cells 4.26
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 4.19
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 4.18
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 4.15
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 4.15
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 4.15
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 4.08
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 4.03
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 4.0
Proliferation-correlated expression 4.0
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 3.98
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 3.97
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 3.97
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 3.92
CD74 role in transcription regulation 3.91
CD74 role in transcription regulation [RNA-seq] 3.91
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 3.9
Silencing SPIB in attached and floating state of H1703 lung cancer cells 3.9
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 3.84
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 3.84
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 3.84
Hijacking of stress response machinery by oncogenes in acute leukaemia 3.84
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 3.83
Identification of global regulators of T-helper cell lineage specification 3.83
Transcriptome of activated human and mouse MAIT cells 3.76
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 3.72
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 3.72
Regulating Interleukin-2 activity with engineered receptor signaling clamps 3.72
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 3.69
Transcriptome analysis revealed impaired cAMP responsiveness in PHF21A-deficient human cells 3.64
mRNA-sequencing of breast cancer subtypes and normal tissue 3.63
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 3.63
Gene expression profile of CRC-derived HILEC 3.63
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 3.62
3.62
hTERT promotes cell adhesion and migration independent of telomerase activity 3.62
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 3.59
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 3.56
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 3.53
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 3.53
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 3.52
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 3.52
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 3.52
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 3.51
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 3.51
Identification and validation of differentially expressed transcripts by RNA-Sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis 3.47
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 3.46
MYCi975 regulates MYC target genes 3.45
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 3.42
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 3.42
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 3.42
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 3.39
Effect of disulfiram treatment on pediatric high grade glioma 3.38
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 3.36
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 3.35
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 3.34
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 3.34
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 3.32
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 3.27
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 3.27
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 3.26
The MEF2B Regulatory Network - RNA-seq data 3.25
The MEF2B Regulatory Network 3.25
Transcriptional effect of ETV1 knockdown in melanoma cells 3.25
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 3.24
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 3.23
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 3.23
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 3.23
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 3.23
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 3.22
RNA-seq analysis of AML cells in response to ASLAN003 3.21
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 3.18
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 3.18
Transcriptomic analysis of human tonsillar TFH subsets 3.16
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 3.16
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 3.14
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 3.14
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 3.14
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 3.14
Global gene expression profile of dasatinib-resistant RCH-ACV cells 3.11
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 3.07
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 3.04
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 3.04
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 3.0
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 2.97
Altering cancer transcriptomes using epigenomic inhibitors 2.97
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 2.95
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 2.94
Transcriptome Profiling of Human Primary Monocytes 2.93
Dermal endothelial cells of type 2 diabetic patients 2.89
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  2.85
Interferon-γ Converts Human Microvascular Pericytes into Negative Regulators of Alloimmunity through Induction of Indoleamine 2,3-Dioxygenase 1 2.85
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 2.83
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 2.82
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 2.82
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 2.8
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 2.77
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 2.77
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 2.76
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 2.73
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 2.73
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 2.72
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 2.7
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 2.7
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 2.66
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 2.6
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 2.6
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 2.59
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 2.59
Be1 and Be2 B cells are transcriptionally distinct 2.57
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 2.5
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 2.5
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 2.5
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 2.5
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 2.5
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 2.5
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 2.48
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 2.44
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 2.43
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 2.41
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 2.41
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 2.38
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 2.38
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 2.35
Single-cell analysis of adult human ovary using 10X genomics 2.32
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 2.3
Transcriptome analysis of human lung epithelial cells 2.26
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 2.22
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 2.21
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 2.19
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 2.19
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 2.18
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 2.16
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 2.15
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 2.13
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 2.13
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 2.13
CD73 knockdown effect in pancreatic cancer cell lines 2.13
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 2.09
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 2.09
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 2.07
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 2.06
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 2.06
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 2.05
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 2.05
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 2.02
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 2.01
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 2.0
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 1.98
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 1.96
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 1.95
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 1.95
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 1.95
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 1.94
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 1.91
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 1.91
Effect of hyper-and hypoactivation of Notch signaling in IL-4-stimulate THP-1 1.91
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 1.91
RNA-seq in endometrial stromal tumors 1.91
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 1.9
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 1.89
Dysregulated immune system networks in war veterans with PTSD 1.88
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 1.84
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 1.8
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 1.79
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 1.78
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 1.78
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 1.76
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 1.76
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 1.74
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 1.74
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 1.73
TT-Seq captures the human transient transcriptome 1.69
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 1.68
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 1.67
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 1.66
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 1.65
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 1.65
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 1.65
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 1.63
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 1.62
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 1.59
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 1.57
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 1.56
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 1.56
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 1.56
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.54
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 1.54
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 1.53
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 1.5
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 1.49
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 1.49
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 1.48
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 1.47
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 1.47
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 1.45
Morphological and molecular characterization of human dermal lymphatic collectors 1.44
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 1.43
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 1.41
The role of m6A/m-RNA methylation in stress response regulation 1.41
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 1.34
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 1.34
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 1.32
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 1.32
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 1.32
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 1.31
Impact on erythroid progenitor type on erythroid differntiation 1.28
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 1.28
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 1.28
RNA expression profiles comparing primary and omental ovarian carcinoma samples 1.24
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 1.24
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 1.24
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 1.24
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 1.23
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 1.2
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 1.2
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 1.19
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 1.15
Transcriptional dependencies in diffuse intrinsic pontine glioma 1.13
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 1.1
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 1.1
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 1.1
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 1.08
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 1.07
Genome-wide chromatin analysis of Ewing sarcoma 1.05
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 1.05
naive T cell heterogeneity after neonatal thymectomy 1.04
Identification of long noncoding RNAs in T-ALL cell lines 1.04
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 1.02
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 1.02
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 0.97
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 0.96
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 0.95
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 0.94
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 0.92
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 0.92
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 0.92
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 0.9
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 0.89
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 0.88
Targeted enhancer activation by a subunit of the integrator complex 0.88
Selective suppression of endothelial cytokine production by progesterone receptor 0.87
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 0.87
RNA-seq in neurons derived from iPSCs in controls and patients with schizophrenia and 22q11 del 0.87
Functional significance of the HIV-1 Tat signature amino acid residues 0.85
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 0.85
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 0.75
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 0.75
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.75
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.75
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 0.75
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.73
Leucegene: AML sequencing (part 6) 0.71
Gene expression activation in CLL mediated by MSCs contact 0.7
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 0.69
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 0.69
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 0.67
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 0.66
Non-coding regions are the main source of tumor-specific antigens [human] 0.66
Non-coding regions are the main source of tumor-specific antigens 0.66
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 0.64
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 0.64
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 0.63
Gene expression profiling in metabolically heterogeneous human lung tumors 0.62
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 0.62
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 0.6
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 0.59
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 0.58
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 0.57
Aortic Valve Tissue: Stenosis vs. Sclerosis 0.56
Intron retention induced by microsatellite expansions as a disease biomarker. 0.55
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 0.54
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 0.51
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 0.49
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.48
Macrophage Ad5f35 PhenoMap 0.47
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 0.46
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 0.46
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.46
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 0.44
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 0.42
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 0.42
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 0.42
Leucegene: ALL sequencing 0.41
RNA-seq analysis of the human fetal kidney. 0.41
Necroptosis inhibition protects from dopaminergic neuronal cell death in OPA1 mutant Parkinson’s disease patient neurons and MPTP treated mice 0.4
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 0.39
BACH2 in human plasma cell fate decision 0.38
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 0.38
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 0.37
MAIT cell RNA sequencing 0.37
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 0.35
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 0.34
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 0.32
A map of gene expression in neutrophil-like cell lines 0.32
miRNAs affected by antagomiR-17 treatment 0.31
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 0.3
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.28
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.28
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.28
RNA-seq of cancer cell lines treated with T-025 0.28
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 0.28
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 0.26
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 0.25
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.25
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 0.24
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 0.23
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 0.21
The cytokine environment influence on human skin-derived T cells 0.19
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 0.19
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 0.19
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 0.18
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 0.17
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 0.15
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 0.15
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 0.13
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 0.13
Human Tfh cell RNA bulk sequencing 0.12
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 0.11
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 0.11
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 0.1
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 0.1
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 0.09
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 0.08
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.07
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.06
RNAseq of Breast cancer PDX samples 0.06
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 0.05
Expression profiling of converted and control dermal BJ fibroblasts 0.05
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 0.05
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.05
Single cell transcriptome of peritoneal cells 0.04
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.04
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 0.03
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 0.02
Gene expression analysis upon mtDNA depletion [RNA-seq] 0.02
Gene expression analysis upon mtDNA depletion 0.02
Total RNA-Seq data from leukemic patients with complex structural variants 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation